Open access
Aug 2026
Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy
Simple Summary Natural killer cells are promising candidates for cellular therapy after allogeneic hematopoietic stem cell transplantation because they can help control malignant cells and viral infections with a low risk of graft-versus-host disease. However, the ability to manufacture these cells consistently under g...
Rut Meseguer, Cristóbal Aguilar, P. Amat et al.
· Cancers · 0 citations